Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay
Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its registration submission to the.
Industry News
Survey Reports That Patients Want Oral Cancer Screenings and Education
More than 49,750 people in the United States will be diagnosed with oral cancer this year, according to Vigilant Biosciences. Yet 62% of.
- April 19, 2017
- 4 minutes read
Industry News
Survey Reports That Patients Want Oral Cancer Screenings and Education
More than 49,750 people in the United States will be diagnosed with oral cancer this year, according to Vigilant Biosciences. Yet 62% of.
- April 19, 2017
- 4 minutes read
Todays Dental News
Awareness Is the Key to Fighting Oral Cancer
April is Oral Cancer Awareness Month, and dentistrytoday.com will be celebrating the event with blogs, news stories, and other features all spotlighting the.
- April 13, 2017
- 4 minutes read
Industry News
Oral Cancer Test Gets European Conformity (CE) Mark
Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer RAPID Test, enabling the company to market the product.
- May 6, 2016
- 1 minute read
Todays Dental News
Statistics Alone Don’t Reveal Oral Cancer’s Terrible Toll
While many of us may have heard the horrific statistics associated with oral cancer, the personal stories behind those figures often go overlooked..
- April 21, 2016
- 5 minutes read
Industry News
Patients Want More Oral Cancer Education
Despite the dental community’s educational efforts during Oral Cancer Awareness Month each April, 58% of American adults know little or nothing about oral.
- April 6, 2016
- 2 minutes read
Industry News
Cancer Detection Tool Earns CE Mark
The OncAlert Oral Cancer CD44/Total Protein LAB Test from Vigilant Biosciences now has the CE Mark, which means it has been approved for.
- November 18, 2015
- 1 minute read
Todays Dental News
Personal Journey Drives Cancer Innovation
Today’s oral cancer detection products typically rely on revealing abnormalities or detecting HPV. Yet these tests aren’t necessarily accurate or timely, discovering dangers.
- August 28, 2015
- 9 minutes read
Industry News
Companies Ink Deal for Oral Cancer Detection Products
Vigilant Biosciences has struck a three-year deal with Crown Dental + Medical Limited to distribute the OncAlert Oral Cancer Risk Assessment System in New Zealand..
- August 20, 2015
- 2 minutes read
